1 – 10 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Ultrahypofraktionerad strålbehandling vid lokaliserad prostatacancer i klinisk vardag: en kohortbeskrivning från Skånes universitetssjukhus
(2026) Onkologidagarna 2026
- Contribution to conference › Poster
-
Mark
Six versus five fractions per week (chemo)-radiotherapy for locally advanced head and neck squamous cell carcinoma – A nationwide cohort study from the Swedish head and neck cancer register
- Contribution to journal › Article
-
Mark
Circulating Tumor DNA in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma—Are We Ready to Individualize Treatment?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Photon FLASH spares radiation-induced changes in cardiac function, remodelling and arrythmia in a preclinical model
- Contribution to journal › Article
-
Mark
Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436
(2026) In European Urology
- Contribution to journal › Letter
-
Mark
External Validation of Pre-Treatment Primary Tumor Volume as a Prognostic Factor in Head and Neck Cancer Treated With (Chemo)Radiotherapy
(2026) In Head and Neck
- Contribution to journal › Article
-
Mark
Daily adaptive radiotherapy in head and neck squamous cell carcinoma can negatively impact organ at risk dosimetry
- Contribution to journal › Article
-
Mark
Radiotherapy with or without concurrent cetuximab in HPV-positive oropharyngeal squamous cell carcinoma – A pooled analysis from two ARTSCAN trials
- Contribution to journal › Letter
-
Mark
Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC
- Contribution to journal › Article
-
Mark
Chemoradiation Therapy Versus Radiation Therapy Alone in T1-2 Oropharyngeal Cancer With Low-Volume Neck Disease: A Population-Based Cohort Study Using the Swedish Head and Neck Cancer Register
- Contribution to journal › Article
